Clinical trials
Lymphoma, Follicular trials in Israel
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 6 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Active, not recruiting | 12 |
| Terminated | 10 |
| Recruiting | 7 |
| Unknown status | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AbbVie | 5 |
| Janssen Research & Development, LLC | 4 |
| Regeneron Pharmaceuticals | 4 |
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Gilead Sciences | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Genmab | 2 |
| German High-Grade Non-Hodgkin's Lymphoma Study Group | 2 |
| Incyte Corporation | 2 |
| ADC Therapeutics S.A. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, Follicular | 50 |
| Lymphoma, B-Cell, Marginal Zone | 17 |
| Lymphoma, Large B-Cell, Diffuse | 17 |
| Lymphoma, Non-Hodgkin | 16 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 14 |
| Lymphoma, Mantle-Cell | 13 |
| Lymphoma | 10 |
| Waldenstrom Macroglobulinemia | 9 |
| Neoplasms | 6 |
| Burkitt Lymphoma | 5 |
Trials
Showing 1 to 25 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.